Galenica (FRA:G70) Market Cap: €4,558 Mil (As of Jul. 01, 2026)


FRA:G70 Galenica Ltd FRA:G70
74 GF Score
Price €92.20
GF Value €92.25
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Galenica Market Cap?

Galenica FRA:G70 -0.75% 74 Market Cap is €4,558 Mil as of Jul. 01, 2026. GuruFocus rates FRA:G70 with a GF Score™ of 74/100 and a GF Value™ of €92.25 (Fairly Valued). The stock has 1 warning sign investors should review. Among 120 Medical Distribution companies, Galenica ranks better than 93.33% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Galenica's share price for the quarter that ended in Dec. 2025 was €103.8. Galenica's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 50 Mil. Therefore, Galenica's market cap for the quarter that ended in Dec. 2025 was €5,172 Mil.

Galenica's quarterly market cap increased from Dec. 2024 (€2,191 Mil) to Jun. 2025 (€4,572 Mil) and increased from Jun. 2025 (€4,572 Mil) to Dec. 2025 (€5,172 Mil).

Galenica's annual market cap declined from Dec. 2023 (€2,192 Mil) to Dec. 2024 (€2,191 Mil) but then increased from Dec. 2024 (€2,191 Mil) to Dec. 2025 (€5,172 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Galenica's Enterprise Value for Today is €4,700 Mil.


Galenica  (FRA:G70) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Galenica Market Cap Related Terms


Galenica Market Cap Historical Data

* Premium members only.

The historical data trend for Galenica's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galenica Market Cap Chart

Galenica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,183.08 2,190.91 2,191.61 2,191.39 5,171.73

Galenica Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,191.61 2,191.61 2,191.39 4,571.63 5,171.73

FRA:G70 vs MCK, CAH, COR: Market Cap Comparison

For the Medical Distribution subindustry, Galenica's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galenica Market Cap vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Galenica's Market Cap distribution charts can be found below:

* The bar in red indicates where Galenica's Market Cap falls into.


FRA:G70
74GF Score
Galenica Ltd FRA:G70
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galenica Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Galenica's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€103.8*49.824
=€5,172

Galenica's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=€103.8*49.824
=€5,172

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €4,558 Mil mean?
Galenica (FRA:G70) has a Market Cap of €4,558 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Galenica and its competitors. According to the industry distribution chart, Galenica ranks #8 out of 120 companies in the Medical Distribution industry, placing it in the top 6.7%.
Is Galenica's Market Cap too high?
Galenica's current Market Cap is €4,558 Mil. Based on the distribution chart, Galenica ranks #8 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Galenica has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Galenica's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Galenica ranks #8 out of 120 companies for Market Cap. This places Galenica in the top 7% of its industry — outperforming the majority of peers. The industry median Market Cap is 144.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 144.63, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median Market Cap is 144.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current Market Cap is €4,558 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Based on GuruFocus' analysis, Galenica (FRA:G70) is currently considered Fairly Valued. The stock's GF Value™ is €92.25, compared to a current price of €92.20 — trading 0.1% below its estimated fair value. The current Market Cap is €4,558 Mil. Galenica's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Galenica (FRA:G70), the current Market Cap is €4,558 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Galenica (FRA:G70) Overvalued in 2026?

Based on GuruFocus' analysis, Galenica stock appears to be undervalued. The current stock price of €92.20 is trading 0.1% below its estimated GF Value™ of €92.25. GuruFocus considers Galenica to be Fairly Valued.

Key valuation signals for FRA:G70:

  • Market Cap: €4,558 Mil
  • GF Value™: €92.25 vs. price of €92.20 (0.1% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the FRA:G70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Galenica Business Description

Address Untermattweg 8, Bern, CHE, CH-3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
74GF Score

Get the complete analysis for FRA:G70

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€92.20
Price
€92.25
GF Value